New keyhole surgery for salivary gland tumors shows promise
NCT ID NCT07600112
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new, minimally invasive keyhole surgery (endoscopic parotidectomy) to the standard open surgery for removing benign (non-cancerous) tumors from the parotid gland, a major salivary gland. The goal is to see if the keyhole approach is as safe and effective, with better cosmetic results and fewer complications. The study involves 46 adults with small, superficial tumors.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Endoscopic parotidectomy (minimally invasive surgery)
- What this could lead to
- If successful, this could offer patients a less invasive option for removing benign parotid tumors, with smaller scars and potentially faster recovery.
- What could go wrong
- This is a small, early-stage study with only 46 participants, so results may not apply to everyone. The endoscopic technique may not be suitable for all tumor types or sizes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 46 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2026
- Expected to finish
-
Jun 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adults aged 18 years or older 2. Patients with benign parotid tumors involving the superficial lobe of the parotid gland 3. Tumors located in the inferior pole with or without limited deep lobe extension 4. Tumor size suitable for minimally invasive approach ≤4 cm 5. Patients fit for surgery under general anesthesia 6. Patients willing to provide informed consent and comply with follow-up Exclusion Criteria: 1. Recurrent parotid tumors 2. Previous parotid surgery on the affected side 3. Pre-existing facial nerve dysfunction 4. Previous neck surgery or extensive cervical/anterior chest wall scarring 5. Significant comorbidities contraindicating surgery or general anesthesia 6. Suspected or confirmed malignant parotid tumors
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign parotid tumors are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of General Surgery, Maxillofacial and Head and Neck Unit
Asyut, 2063045, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.